Overall these data indicate that in either melanoma model targeting FAP+ tumor stroma cells reduces the content of MDSCs within tumors, which may create a more supportive niche for antigen-specific TILs by reducing their metabolic stress. This evidence concerns the gene FAP and melanoma.